Fig. 3.
Distribution of participants’ Montgomery-Åsberg Depression Rating Scale suicide item (MADRS-SI) scores at study baseline and over six repeated ketamine infusions in Phase 2 (N = 37).
Distribution of participants’ Montgomery-Åsberg Depression Rating Scale suicide item (MADRS-SI) scores at study baseline and over six repeated ketamine infusions in Phase 2 (N = 37).